# ğŸ”¬ HelioFlux Interactive Patient Journey â€” Claude Code Handoff

> **For:** Claude Code / Coding Agent  
> **Created by:** Kelly Lucas + Kip ğŸ¦‰  
> **Date:** February 11, 2026  
> **Company:** HelioFlux (biophotonic cancer detection)  
> **Live Version:** https://kellylucas314-cpu.github.io/helioflux-journey/

---

## ğŸ“‹ TABLE OF CONTENTS

1. [Project Overview](#project-overview)
2. [The Core Insight](#the-core-insight)
3. [Maya's Story (The Narrative)](#mayas-story)
4. [Screen-by-Screen Content](#screen-by-screen-content)
5. [Visual Design System](#visual-design-system)
6. [The Science (Accurate Data)](#the-science)
7. [Technical Implementation](#technical-implementation)
8. [Current Code](#current-code)
9. [Enhancement Ideas](#enhancement-ideas)
10. [Legal & Compliance](#legal--compliance)

---

## ğŸ¯ PROJECT OVERVIEW

### What This Is
An interactive, narrative-driven web experience that shows why early cancer detection matters â€” through the lens of a relatable patient story.

### Why It Exists
- **Pitch meetings:** Demo on laptop, create emotional connection investors remember
- **Website:** Engaging content that keeps visitors longer than a static deck
- **Education:** Help people understand the problem HelioFlux solves
- **Differentiation:** Most biotech sites are boring; this stands out

### The Goal
Make people FEEL the gap between "let's watch it" and "it's too late" â€” then show how HelioFlux fills that gap.

### Target Audience
1. **Investors** â€” angels, family offices, VCs interested in biotech
2. **Clinical partners** â€” hospitals, dermatology practices, research institutions
3. **General public** â€” people who might one day need this technology

---

## ğŸ’¡ THE CORE INSIGHT

### The Real Problem (Behavioral)
Most patients don't skip care because they don't care. They skip because:
- The next step is **expensive**
- The next step is **invasive** (biopsy scars, blood draws)
- The next step is **slow** (weeks of waiting)
- The next step is **uncertain** (probably nothing, but maybe not?)

This creates a deadly default path:
```
Notice something â†’ Delay â†’ "Let's watch it" â†’ Busy life â†’ Return when it's worse
```

### The HelioFlux Solution
A quick, non-invasive scan that can help clinicians decide sooner â€” while the lesion is still small.

**HelioFlux exists for the gap between "let's watch it" and "it's too late."**

### Key Messaging Points

| Message | Purpose |
|---------|---------|
| "The Gap Nobody Solves" | Hook â€” identifies the problem |
| "'Let's watch it' is not bad medicine" | Respects clinicians, doesn't blame them |
| "It's what happens when tools are limited" | Positions HelioFlux as enabling, not replacing |
| "Detect metabolic change earlier, when clinicians are still deciding what to do" | Precise, responsible claim |
| "Quick enough to actually happen" | Addresses the behavioral barrier |

---

## ğŸ‘© MAYA'S STORY

### Why Maya (Not Sarah)
The original version used "Sarah" â€” a patient with family history, representing the "high risk" population. But that's actually a small slice of patients.

**Maya represents the majority:**
- No family history
- Not "high risk" by any metric
- Just a regular person who noticed something and delayed

This is more universal and hits the real behavioral bottleneck.

### Maya's Character Profile

| Attribute | Detail |
|-----------|--------|
| Age | Not specified (relatable to 30-60 range) |
| Risk factors | None â€” no family history |
| Trigger | Friend had melanoma years ago |
| Initial symptom | Small change on skin |
| Why she delays | It's a hassle; probably nothing |
| At the doctor | Doesn't want biopsy scar |
| Doctor's response | "Let's watch it" |
| What happens | Life gets busy, months pass |
| Outcome (traditional) | Returns when it's worse |
| Outcome (HelioFlux) | Gets clarity sooner, clear follow-up plan |

### The Narrative Arc

```
RELATABLE TRIGGER â†’ UNDERSTANDABLE DELAY â†’ REASONABLE MEDICAL ADVICE â†’ 
LIFE HAPPENS â†’ CONSEQUENCES â†’ [WHAT IF THERE WAS ANOTHER WAY?]
```

### Story Text (Exact Copy)

**Screen 1 - Intro:**
> Most patients don't skip care because they don't care.
> They skip because the next step is expensive, invasive, slow, or uncertain.

**Screen 2 - Meet Maya:**
> Maya has no family history. She's not a "high-risk" person.
> 
> A friend had melanoma a few years back. That planted a seed â€” weird spots can be serious.
> 
> Maya notices a small change on her skin. She delays because it's a hassle.

**Screen 3 - The Wait:**
> When Maya finally goes in, she doesn't want a biopsy scar for something that's probably nothing.
> 
> The dermatologist says, "Let's watch it."
> 
> So she watches it. Life gets busy. Months pass.
> 
> Then it changes enough that she can't ignore it. She goes back.
> 
> Now it's worse.

**Screen 4 - The Default Path:**
> Notice something â†’ Delay â†’ "Let's watch it" â†’ Busy life â†’ Return when it's worse
> 
> The real failure point is the wait: watchful waiting plus human delay.

**Screen 5 - The HelioFlux Path:**
> Notice something â†’ Quick, non-invasive scan â†’ Earlier clarity â†’ Earlier action
> 
> "Let's watch it" is not bad medicine. It's what happens when the tools are limited. HelioFlux gives doctors a better tool in the watch window.

**Screen 6 - Scale Comparison:**
> 1 Billion Cells â€” Traditional detection threshold
> 10 Million Cells â€” HelioFlux detection target
> 
> 100x earlier detection. While clinicians are still deciding what to do.

**Screen 7 - Technology:**
> Every cell emits ultra-weak photons. The pattern changes when cells change.
> 
> The HelioFlux advantage: detect metabolic change earlier, when clinicians are still deciding what to do.

**Screen 8 - Maya's Outcome:**
> With HelioFlux, Maya doesn't wait months in uncertainty.
> She gets a clear follow-up plan â€” sooner.
> 
> HelioFlux exists for the gap between "let's watch it" and "it's too late."

---

## ğŸ“± SCREEN-BY-SCREEN CONTENT

### Screen 1: The Gap Nobody Solves
**Purpose:** Hook with the core insight

**Visual:** Dark background, floating biophoton particles

**Headline:** "The Gap Nobody Solves"

**Body:** Most patients don't skip care because they don't care. They skip because the next step is expensive, invasive, slow, or uncertain.

**CTA:** "See What We Mean"

---

### Screen 2: Meet Maya
**Purpose:** Introduce relatable character

**Visual:** Simple avatar (warm earth tones), friendly but not photo-realistic

**Headline:** "Maya's Story"

**Body:** 
- No family history, not "high-risk"
- Friend had melanoma â†’ planted a seed
- Notices small skin change
- Delays because it's a hassle

**CTA:** "Continue"

---

### Screen 3: The Wait
**Purpose:** Build tension, show the delay pattern

**Headline:** "The Wait"

**Body:**
- Doesn't want biopsy scar for "probably nothing"
- Doctor says "Let's watch it"
- Life gets busy, months pass
- Returns when it's worse

**Emotional beat:** The line "Now it's worse" should hit hard (styled in red/danger color)

**CTA:** "See the Pattern"

---

### Screen 4: The Default Path
**Purpose:** Visualize the broken system

**Headline:** "The Default Path"

**Visual:** Animated flow diagram (steps appear one by one)

```
Notice something
      â†“
    Delay
      â†“
"Let's watch it"
      â†“
  Busy life
      â†“
Return when it's worse  â† (highlighted in red)
```

**Key message:** "The real failure point is the wait: watchful waiting plus human delay."

**CTA:** "There's a Better Path"

---

### Screen 5: The HelioFlux Path
**Purpose:** Show the solution

**Headline:** "The HelioFlux Path"

**Visual:** Animated flow diagram (teal/green colors)

```
Notice something
      â†“
Quick, non-invasive scan  â† (highlighted in teal)
      â†“
Earlier clarity
      â†“
Earlier action  â† (highlighted in green)
```

**Quote block:**
> "Let's watch it" is not bad medicine.
> It's what happens when the tools are limited. HelioFlux gives doctors a better tool in the watch window.

**CTA:** "See the Scale"

---

### Screen 6: Real-Scale Cell Comparison
**Purpose:** Make the 100x difference visceral

**Headline:** "To Scale: When Detection Happens"

**Visual:** Two circles, proportionally sized by AREA

| Circle | Diameter | Represents |
|--------|----------|------------|
| Large (red) | 220px | 1 billion cells (traditional) |
| Small (green) | 22px | 10 million cells (HelioFlux) |

**Math:** 
- Ratio: 1,000,000,000 / 10,000,000 = 100x
- Area scales with radiusÂ²
- So diameter ratio = âˆš100 = 10x
- If small = 22px, large = 220px

**Note below visualization:** "Circle areas are proportional to cell counts. This is real scale."

**Key message:** "100x earlier detection. While clinicians are still deciding what to do."

**CTA:** "How It Works"

---

### Screen 7: The Technology
**Purpose:** Brief, credible explanation

**Headline:** "Detect Metabolic Change Earlier"

**Body:** Every cell emits ultra-weak photons. The pattern changes when cells change.

**Tech grid (4 items):**

| Icon | Title | Description |
|------|-------|-------------|
| Sun/rays | Biophoton Detection | Reads cellular light emissions |
| Heartbeat | Non-Invasive | No blood. No biopsy. No radiation. |
| Clock | 5-Minute Scan | Quick enough to actually happen |
| Shield | Peer-Reviewed | Published in iScience, 2025 |

**Key message:** "The HelioFlux advantage: detect metabolic change earlier, when clinicians are still deciding what to do."

**CTA:** "Learn More"

---

### Screen 8: Maya's Outcome + CTA
**Purpose:** Resolve the story, convert

**Headline:** "Maya Gets Clarity Sooner"

**Body:** With HelioFlux, Maya doesn't wait months in uncertainty. She gets a clear follow-up plan â€” sooner.

**Quote block:** "HelioFlux exists for the gap between 'let's watch it' and 'it's too late.'"

**CTAs:**
- Primary: "Invest in HelioFlux" â†’ mailto:kelly.lucas@helioflux.co?subject=Investing in HelioFlux
- Secondary: "Partner With Us" â†’ mailto:kelly.lucas@helioflux.co?subject=Partnership Inquiry

**Disclaimer:** HelioFlux is currently in development. Based on peer-reviewed research. Not yet FDA approved. Intended for investigational use only.

**Restart:** "Start Over" button

---

## ğŸ¨ VISUAL DESIGN SYSTEM

### Color Palette

```css
:root {
    /* Primary - Trust & Innovation */
    --helio-blue: #0A2540;        /* Deep navy background */
    --helio-teal: #00B4D8;        /* Brand accent, interactive elements */
    --helio-glow: #7DF9FF;        /* Biophoton glow, highlights */
    
    /* Neutral */
    --warm-white: #F8F9FA;        /* Text */
    --soft-gray: #6C757D;         /* Secondary text, muted elements */
    
    /* Paths */
    --path-a: #8B9CAD;            /* Traditional path (muted) */
    --path-b: #00B4D8;            /* HelioFlux path (vibrant) */
    
    /* States */
    --success: #28A745;           /* Good outcomes, HelioFlux detection */
    --warning: #FFC107;           /* Caution */
    --danger: #DC3545;            /* Bad outcomes, traditional detection */
}
```

### Typography

```css
/* Headlines - Modern, impactful */
font-family: 'Space Grotesk', sans-serif;
font-weight: 600-700;

/* Body - Readable, warm */
font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
font-weight: 400-500;

/* Stats/Numbers - Monospace feel */
font-family: 'Space Grotesk', sans-serif;
font-weight: 700;
```

### Visual Motifs

1. **Biophoton particles** â€” Floating cyan dots in background (subtle, 30 particles)
2. **Gradient headlines** â€” White to cyan gradient on main titles
3. **Card backgrounds** â€” Semi-transparent with blur (glassmorphism)
4. **Flow diagrams** â€” Animated step-by-step reveals
5. **Pulsing circles** â€” For cell size comparison (gentle, not distracting)

### Animation Philosophy

- **Purposeful:** Every animation conveys meaning
- **Subtle:** Medical context requires trust, not flash
- **Progressive:** Information reveals naturally, step by step
- **Smooth:** 0.3-0.8s transitions, ease timing functions

### Icons

Use inline SVGs (not emoji, not icon fonts). Current icons:
- Sun with rays (biophoton)
- Heartbeat line (non-invasive)
- Clock (5-minute scan)
- Shield (peer-reviewed)
- Arrow right (navigation)
- Person silhouette (Maya avatar)

---

## ğŸ”¬ THE SCIENCE (Accurate Data)

### Key Numbers

| Metric | Traditional | HelioFlux |
|--------|-------------|-----------|
| Detection threshold | ~1 billion cells | ~10 million cells |
| Detection ratio | 1x (baseline) | 100x earlier |
| Tumor size at detection | ~1 cm diameter | Pre-tumor / early cellular |
| Test duration | Weeks to months | 5 minutes |
| Invasiveness | Blood draws, biopsies, radiation | Non-invasive sensor |

### Scientific Basis

**Ultra-Weak Photon Emissions (UPEs):**
- All living cells emit photons (biophotons)
- Emission intensity: ~10-1000 photons/cmÂ²/second
- Patterns differ between healthy and abnormal cells
- Detectable with sensitive photomultiplier equipment
- 40+ years of peer-reviewed biophotonics research

**HelioFlux Innovation:**
- Proprietary sensor array optimized for clinical use
- AI/ML pattern recognition for anomaly detection
- Platform technology (not limited to one cancer type)
- Non-invasive, no radiation exposure

**Published Research:**
- iScience 2025 paper (peer-reviewed)
- Dr. Nirosha Murugan (Canada Research Chair, co-founder)
- Multiple wavelength detection validated

### Application Areas

- **Primary focus:** Skin cancer / melanoma (Maya's story)
- **Platform potential:** Brain cancer, chemo brain detection, cell reprogramming
- **Clinical use case:** Decision support during "watchful waiting" period

---

## ğŸ”§ TECHNICAL IMPLEMENTATION

### Current Stack

```
- Pure HTML/CSS/JavaScript (no framework)
- Google Fonts (Inter, Space Grotesk)
- Inline SVG icons
- CSS animations (no JS animation libraries)
- GitHub Pages hosting
```

### File Structure

```
helioflux-interactive/
â”œâ”€â”€ index.html          # Main experience (all-in-one)
â”œâ”€â”€ PATIENT-JOURNEY-SPEC.md   # Original specification
â”œâ”€â”€ CLAUDE-CODE-HANDOFF.md    # This document
â””â”€â”€ README.md           # (to create)
```

### Key Features Implemented

- [x] 8-screen narrative flow
- [x] Progress dots (fixed right side)
- [x] Keyboard navigation (arrows, spacebar)
- [x] Touch/swipe support (mobile)
- [x] Mouse wheel navigation
- [x] Floating particle background
- [x] Animated flow diagrams
- [x] Real-scale cell comparison
- [x] Responsive design
- [x] Smooth screen transitions

### Navigation Logic

```javascript
// Keyboard
ArrowRight, ArrowDown, Space â†’ nextScreen()
ArrowLeft, ArrowUp â†’ prevScreen()

// Touch
Swipe up â†’ nextScreen()
Swipe down â†’ prevScreen()

// Mouse wheel
Scroll down â†’ nextScreen()
Scroll up â†’ prevScreen()

// Click
Progress dots â†’ goToScreen(index)
Buttons â†’ nextScreen()
```

### Animation Timing

| Element | Duration | Easing |
|---------|----------|--------|
| Screen transitions | 0.8s | ease |
| Flow diagram steps | 0.4s each, 0.2s stagger | ease |
| Particle float | 10-20s | ease-in-out |
| Cell pulse | 2-3s | ease-in-out |
| Button hover | 0.3s | ease |

---

## ğŸ“ CURRENT CODE

### Repository
https://github.com/kellylucas314-cpu/helioflux-journey

### Live URL
https://kellylucas314-cpu.github.io/helioflux-journey/

### File Size
- `index.html`: ~32KB (all-in-one, no external dependencies except fonts)

### Browser Support
- Modern browsers (Chrome, Firefox, Safari, Edge)
- Mobile browsers (iOS Safari, Chrome Android)
- No IE11 support (uses CSS custom properties, backdrop-filter)

---

## ğŸš€ ENHANCEMENT IDEAS

### High Priority

1. **Sound design**
   - Subtle ambient music (optional, muted by default)
   - Click sounds on navigation
   - Gentle whoosh on screen transitions

2. **Loading state**
   - Brief loading animation while fonts load
   - Prevent flash of unstyled content

3. **Share functionality**
   - Share buttons on final screen (LinkedIn, Twitter, Email)
   - OpenGraph meta tags (already present, could enhance)

4. **Analytics**
   - Track completion rate per screen
   - Track CTA clicks
   - Identify drop-off points

### Medium Priority

5. **Accessibility improvements**
   - Skip navigation link
   - Screen reader announcements on screen change
   - Reduced motion option
   - High contrast mode

6. **Embed version**
   - Iframe-friendly version for embedding in other sites
   - Configurable width/height

7. **Multiple languages**
   - Extract text to JSON
   - Language selector

8. **Custom Maya illustration**
   - Commission professional character illustration
   - Consistent across screens

### Lower Priority

9. **Video testimonials**
   - Optional video clips from team or advisors
   - Plays inline, doesn't disrupt flow

10. **Interactive cell visualization**
    - Zoom into cell, see photon emissions
    - Educational, but might distract from story

11. **Clinician version**
    - Separate flow focused on clinical workflow
    - More technical language

12. **PWA capabilities**
    - Offline support
    - Install to home screen
    - Works without internet (for demos)

---

## âš–ï¸ LEGAL & COMPLIANCE

### Safe Language (Use These)

- âœ… "Aims to detect"
- âœ… "Detection target"
- âœ… "In development"
- âœ… "Based on peer-reviewed research"
- âœ… "Published in iScience"
- âœ… "Potential to transform"
- âœ… "Non-invasive"
- âœ… "Quick scan"
- âœ… "Earlier clarity"
- âœ… "Clear follow-up plan"

### Avoid (Don't Use)

- âŒ "FDA approved"
- âŒ "Cures cancer"
- âŒ "Diagnoses cancer"
- âŒ "Saved her life"
- âŒ Specific accuracy percentages (pending clinical trials)
- âŒ "Guaranteed" anything
- âŒ "100% accurate"
- âŒ Implying HelioFlux replaces doctor judgment

### Required Disclaimer

Include on final screen:
> HelioFlux is currently in development. Based on peer-reviewed research. Not yet FDA approved. Intended for investigational use only.

### Maya's Outcome (Responsible Framing)

**Good:** "She gets a clear follow-up plan â€” sooner."

**Bad:** "HelioFlux saved her life" or "HelioFlux diagnosed her cancer."

The story shows the problem and the potential â€” it doesn't overclaim the solution.

---

## ğŸ“§ CONTACT

**Kelly Lucas**  
President, HelioFlux  
kelly.lucas@helioflux.co  
(310) 418-0482

**Co-Founder:**  
Dr. Nirosha Murugan  
CEO & Chief Scientist  
Canada Research Chair

---

## ğŸ¯ SUCCESS CRITERIA

The experience is successful when:

- [ ] Investors remember "the circles" (scale visualization)
- [ ] People say "I know someone like Maya"
- [ ] Completion rate >60%
- [ ] Clinicians say "this respects what I do"
- [ ] Lawyers say "this is compliant"
- [ ] Mobile experience feels native

---

## ğŸ“ CHANGELOG

| Date | Version | Changes |
|------|---------|---------|
| 2026-02-11 | v1 | Initial build with Sarah's story |
| 2026-02-11 | v2 | Rewrote with Maya's story, real-scale cells, behavioral framing |

---

*Built with ğŸ¦‰ by Kip for Kelly & HelioFlux â€” February 2026*

*"The gap between 'let's watch it' and 'it's too late.'"*
